CAS 276702-15-9

6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide

Description:

6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide, with the CAS number 276702-15-9, is a synthetic organic compound characterized by its complex structure, which includes a sulfonamide group, a hydroxy group, and a chloro substituent. This compound typically exhibits properties associated with sulfonamides, such as potential antibacterial activity, although its specific biological activity may vary based on its structural features. The presence of multiple chlorine atoms suggests that it may have enhanced lipophilicity and stability, which can influence its pharmacokinetic properties. Additionally, the urea linkage in its structure may contribute to its ability to interact with biological targets, potentially making it relevant in medicinal chemistry. The compound's solubility, melting point, and reactivity would depend on its specific molecular interactions and the environment in which it is studied. Overall, this compound represents a class of molecules that may have applications in pharmaceuticals or agrochemicals, warranting further investigation into its properties and potential uses.

Formula: C₁₃H₁₀Cl₃N₃O₄S

Synonyms:

• 332235
• Sb-332235

SB-332235 (6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide)

CAS: 276702-15-9

Formula: C₁₃H₁₀Cl₃N₃O₄S

Molecular weight: 410.67

Ref: 4Z-U-065

SB 332235

CAS: 276702-15-9

SB 332235 is a small molecule that binds to the chemokine receptor CXCR2 and blocks the binding of the chemokine IL-8. SB 332235 has been shown to inhibit neutrophil recruitment and reduce inflammation in animal models. SB 332235 is orally active and does not affect blood pressure or heart rate in animals. The drug also reduces levels of the inflammatory cytokine TNF-α and increases levels of the anti-inflammatory cytokine IL-10. SB 332235 has been used as a diagnostic agent for detection of autoimmune diseases, cancer, or inflammatory diseases. It has not yet been approved for clinical use in humans.

Formula: C₁₃H₁₀Cl₃N₃O₄S

Purity: Min. 95%

Molecular weight: 410.7 g/mol

Ref: 3D-BLA70215

SB-332235

CAS: 276702-15-9

SB-332235 is an effective specific CXCR2 antagonist. And it is effectively inhibited CS-induced neutrophilia in a dose-dependent manner.

Formula: C₁₃H₁₀Cl₃N₃O₄S

Color and Shape: Solid

Molecular weight: 410.66

Ref: TM-T34544